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Abstract Following stroke, complete cellular death in the
ischemic brain area may ensue, with remaining brain areas
undergoing tissue remodelling to various degrees.
Experience-dependent brain plasticity exerted through an
enriched environment (EE) promotes remodelling after central
nervous system injury, such as stroke. Post-stroke tissue reor-
ganization is modulated by growth inhibitory molecules dif-
ferentially expressed within the ischemic hemisphere, like
chondroitin sulfate proteoglycans found in perineuronal nets
(PNNs). PNNs in the neocortex predominantly enwrap
parvalbumin-containing GABAergic (PV/GABA) neurons,
important in sensori-information processing. Here, we
investigate how extracellular matrix (ECM) proteases and
their inhibitors may participate in the regulation of PNN in-
tegrity during stroke recovery. Rats were subjected to
photothrombotic stroke in the motor cortex, and functional
deficits were assessed at 7 days of recovery. Sham and stroked
rats were housed in either standard or EE conditions for 5 days,
and infarct volumes were calculated. PNNswere visualized by
immunohistochemistry and counted in the somatosensory cor-
tex of both hemispheres. mRNA expression levels of ECM
proteases and protease inhibitors were assessed by RT-qPCR
and their activity analyzed by gel zymography. PNNs and
protease activity were also studied in brains from stroke pa-
tients where similar results were observed. EE starting 2 days
after stroke and continuing for 5 days stimulated behavioral
recovery of limb-placement ability without affecting infarct
size. EE promoted a decrease of PNNs around PV/GABA
neurons and a concomitant modulation of the proteolytic ac-
tivity and mRNA expression of ECM proteases and protease
inhibitors in the somatosensory cortex. This study provides
molecular targets for novel therapies that could support reha-
bilitation of stroke patients.
Keywords Stroke recovery . Experience-dependent
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Introduction
According to the World Health Organization, approximately
15 million people suffer stroke worldwide each year. Of these,
five million die and another five million are permanently dis-
abled, making stroke a global leading cause of death and long-
Electronic supplementary material The online version of this article
(doi:10.1007/s12035-017-0461-2) contains supplementary material,
which is available to authorized users.
* Miriana Jlenia Quattromani
miriana.quattromani@med.lu.se
1 Laboratory for Experimental Brain Research, Division of
Neurosurgery, Department of Clinical Sciences, Lund University,
BMC A13, 22184 Lund, Sweden
2 INSERM UMR-S U919, Serine Proteases and Pathophysiology of
the Neurovascular Unit, Université Caen Basse Normandie, GIP
Cyceron, F-14074 Caen, France
3 Division of Oncology and Pathology, Lund University Hospital,
22185 Lund, Sweden
4 Rheumatology and Molecular Skeletal Biology, Department of
Clinical Sciences, Lund University, BMCC12, 22184 Lund, Sweden
5 Laboratory of Neurobiology, Nencki Institute of Experimental
Biology, 02-093 Warsaw, Poland
6 Department of Clinical Research, Caen University Hospital, CHU
Caen, 14000 Caen, France
Mol Neurobiol
DOI 10.1007/s12035-017-0461-2
term disability [1, 2]. Stroke treatment options are restricted to
the few hours after the accident [3, 4], and beyond that thera-
peutic window, treatment is limited to supportive care and
rehabilitation. Yet, most stroke patients recover to some ex-
tent, demonstrating that remarkable brain plasticity is retained
after the injury and that the recovery process should emerge as
a promising target in stroke research [5].
The current experimental evidence strongly suggests that
multisensory stimulation by changes in the environment (such
as enriched environment (EE)) as well as task-driven experi-
ence confer an additive benefit on behavioral recovery after
brain insults such as stroke, most likely because of their im-
pact on brain plasticity [6, 7]. This promising approach has
been recently translated into the clinical practice [8–10].
EE provides laboratory animals with novelty and extra
space, allowing different forms of multisensory stimulation
ranging from social grouping to enhanced motor activity. EE
results in improved cognitive and sensorimotor functions both
in naive rodents and in animals with brain lesions such as
those occurring after a stroke. In animals which have suffered
a stroke, robust behavioral effects are seen during recovery
and are probably related not only to neuronal plasticity in
the peri-infarct cortex but also in remote brain areas [7,
11–13].
After stroke, a number of growth inhibitory molecules
are differentially expressed within the peri-infarct region,
leading to inhibition of neuronal plasticity [14, 15].
Interestingly, in areas more distant from the infarct, there
is a reduction in the number of these inhibitory molecules,
particularly in chondroitin sulfate proteoglycans (CSPGs)
and their formation into dense lattice-like structures termed
perineuronal nets (PNNs) [15–18]. PNNs are considered a
specialized form of extracellular matrix (ECM) with a ma-
jor role in establishing and stabilizing connectivity in the
brain by restricting plasticity. They are typically localized
around inhibitory neurons [19], but they have been also
described around excitatory pyramidal neurons [20–22].
CSPGs present in PNNs are lecticans and include
aggrecan, brevican, neurocan, and versican, with aggrecan
exclusively present in PNNs and therefore being a specific
marker for PNNs in the adult brain [23]. We have recently
shown that 9 weeks of EE after stroke induce a further
reduction in the number of these inhibitory molecules, es-
pecially Cat-315+ (aggrecan-containing) PNNs [12],
supporting the idea that part of the peri-infarct and remote
cortex possesses an environment for post-stroke response
strategies [24]. Several proteases are involved in the re-
modelling of ECM and PNNs, including tissue plasmino-
gen activator (tPA) [25], type 4 disintegrin and metallopro-
teinase with thrombospondin motifs (ADAMTS-4) [25],
and matrix metalloproteinases (MMPs) such as MMP-2
and MMP-9 [26–28]. tPA is a serine protease present in
the blood, in the brain and at the interface between the
blood and the brain [29]. In the brain parenchyma, tPA is
expressed and released by endothelial cells, neurons, astro-
cytes, microglia, and oligodendrocytes. tPA contributes to
ECM degradation, influence cell migration, neuronal plas-
ticity, death and survival of neurons, endothelial cells, and
oligodendrocytes [29]. ADAMTS-4 has been described in
the brain parenchyma, mainly in astrocytes, neurons, mi-
croglia, and monocyte/macrophages and is involved in
several central nervous system (CNS) functions, including
neurorepair, remyelination, angiogenesis, and inflamma-
tion [30]. Cleavage by tPA produces the active form of
ADAMTS-4, which then degrades inhibitory CSPGs, lead-
ing to increased neurite growth and subsequent functional
recovery [25]. The MMP family of proteases act outside
the cells and are therefore associated with ECM remodel-
ling. They are expressed in neurons, glia, and endothelial
cells and are involved in a number of physiological and
pathological conditions, including development, tissue re-
modelling, inflammation, and metastasis [31]. Current data
suggest that MMPs (such as MMP-2 and MMP-9) mediate
beneficial dendritic plasticity and ECM remodeling at de-
layed stages after stroke [28]. Multiple studies showed in-
creased expression and activity of MMP-2 and MMP-9
after brain injury (such as stroke) during the recovery
phase [28, 31]. In particular, MMP-9 has been implicated
in synaptic plasticity, learning and memory, and tissue re-
modelling in response to enhanced neuronal activity [32,
33]. Inhibitors of these proteases (such as neuroserpin, tis-
sue inhibitor of metalloproteinases TIMP-1 and TIMP-3)
are also considered strategic in promoting neuronal remod-
elling and neuroplasticity in the CNS [29, 34].
The aim of this study was to further investigate the influ-
ence of multisensory brain stimulation provided by EE after
stroke on PNN integrity and on changes in expression/activity




A total of 40 adult male Sprague-Dawley rats (8–11 weeks,
Charles River) were used in this study and housed under re-
verse light conditions with free access to food and water.
Physiological data are given in Supplement Table 1.
Human Postmortem Brain Tissue
A total of ten stroke (n = 5) and non-stroke (n = 5) cases were
used in this study. Age, sex, cause of death, and postmortem
delay are given in Supplement Table 2.
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Experimental Stroke
Animals underwent permanent focal ischemia by
photothrombosis (PT) in the left hemisphere as previously
described [12, 35] or sham operation (same procedure as PT,
but without illumination). During surgery, the body tempera-
ture of the animals was kept at 37 °C using a self-regulating
heating pad. Briefly, isoflurane-anesthetized rats (2% in O2
under spontaneous ventilation) received intravenous injec-
tions of the photosensitive dye Rose Bengal (10 mg/ml,
Sigma, USA) in the tail vein. The skin above the skull was
incised, and the brain was illuminated through the exposed
skull with cold light (KL 1500 LCD, Schott) for 15 min at a
stereotactically defined position (0.5 mm laterally and +4/
−4 mm anterior/posterior to bregma), producing an approxi-
mate irradiation area of 8 × 4 mm2. Incisions were sutured,
and animals were allowed to awake from anesthesia while on
a heating pad and returned to their home cages.
Behavioral Assessment and Randomization
Paw Placement Test Sensorimotor function and touch sen-
sation were assessed by the paw placement test, which
provides information on the tactile/proprioceptive re-
sponse to limb stimulation [12, 36]. Testing at all times
was performed by the same investigator. In brief, every rat
was placed with all paws on a bench surface and hand-
held in a horizontal position. Facial contact stimuli were
avoided by supporting the rat’s chin and holding its head
45° upward. The paws to be tested were gently pushed
along the edge in order to loose contact with the bench
surface. The ability of the rat to place the limb back on
the bench surface when the animal was moved along its
edge was evaluated with the following score: (1) prompt
placement of the limb on the table, (0.5) incomplete
placing of the limb, (0) no response, with persistent ex-
tension of the limb and paw.
One day before PT or sham operations, all animals had a
score = 1 in each of the four paws, indicating that no deficit in
sensorimotor function was present before the surgeries.
Differential Housing Conditions Two days after surgeries,
both PT and sham animals were assigned to either group I
or II (n = 20 each) and randomized into (standard) STD or
EE cages [12] where they were housed for 5 days. Rats
housed in STD conditions had one cage mate, and rats in
enriched cages had up to five mates. Multilevel EE cages
were equipped with various colored objects such as plas-
tic tunnels, removable platforms, grids, pipes, ropes, lad-
ders, and chains. The disposition of the objects was
changed twice/week.
The animals were divided as described in Fig. 1. Brains
from groups I and II were collected and handled accord-
ingly to postmortem analyses. Brain samples from group I
were used for immunohistochemical analyses (infarct
measurements and cell counting). Animals from group II
were used for behavioral assessments on day 7, and after
sacrifice, the brains from this group were used for molec-
ular biology experiments (gel-zymography, western blot,
RT-qPCR).
Brain Preparation from Rats
Group I Rats were anesthetized with 4% isoflurane and
transcardially perfused with 0.9% NaCl followed by cold
phosphate-buffered 4% paraformaldehyde (PFA, Sigma,
USA), pH 7.4. Brains were postfixed overnight in PFA and
equilibrated in phosphate-buffered 30% sucrose for 48 h at
4 °C. Brains were sectioned in the coronal plane on a micro-
tome at 30-μm intervals. Sections were collected and stored at
Fig. 1 Experimental design. Rats were pre-tested to assess their full limb
placement ability 1 day before photothrombosis (PT) or sham operations.
Functional deficits were assessed 2 days after PTand rats were selectively
sorted into differential housing conditions (standard, STD; enriched, EE).
Differential housing was continued for the five following days. At 7 days
of recovery, brains were perfusion-fixed (group I) or frozen (group II) for
further analyses
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−20 °C in an antifreeze solution made in phosphate buffer
containing 30% glycerol and 30% ethylene glycol.
Group II Rats were anesthetized with 4% isoflurane and per-
fused with cold heparinized 0.9%NaCl. Brains were extracted
and immediately frozen by immersion in isopentane and dry
ice. Brains were then stored at −80 °C until dissection. On the
day of the dissection, frozen brains were moved to a −20 °C
chamber and placed in a rat brain matrix. Two brain slices 2-
mm-thick (2.20 to −3.30 mm from bregma) were excised
using a scalpel blade. The primary somatosensory cortex on
both ipsilateral and contralateral hemispheres was cut out ac-
cording to Paxinos and Watson [37]. In the ipsilateral hemi-
sphere, the sampling started 1 mm after the end of the lesion.
Samples were transferred to tubes and stored at −80 °C until
further use.
Brain Preparation from Patients
Following autopsy, cortical fresh tissue from the infarct core,
peri-infarct, and remote regions were dissected out by a pa-
thologist, immediately frozen and stored at −80 °C. For further
dissection, samples were temporarily moved to a −20 °C
chamber where smaller specimens were excised and stored
at −80 °C until protein extraction.
Immunohistochemistry and Immunofluorescence
(IHC/IF)
Rat Brain Tissue Free-floating brain slices from group I were
rinsed in phosphate-buffered solution (PBS), quenched in 3%
H2O2 and 10% methanol for 15 min (IHC) and blocked in
blocking solution (5% normal donkey serum, Jackson
ImmunoResearch, UK, and 0.25% Triton X-100 in PBS) for
1 h at room temperature (RT). Sections were incubated over-
night at 4 °C with primary antibodies (monoclonal mouse
anti-CSPGs, 1:3000 for IHC and 1:1000 for IF, Cat-315/
MAB1581, Millipore, USA; goat anti-parvalbumin (PV),
1:2500 for IF, PVG-214, Swant, Switzerland) diluted in
blocking solution. Following rinses with 2% normal donkey
serum and 0.25% Triton X-100 in PBS, the sections were
incubated with appropriate secondary antibodies (donkey
anti-mouse for IHC, Vector Laboratories, USA; donkey anti-
mouse/goat conjugated with either Cy3 or DyLight 488 fluo-
rescent dyes for IF, Jackson ImmunoResearch, UK) at a dilu-
tion of 1:400 in blocking solution for 90 min at RT. IHC
visualization was achieved via the Vectastain ABC kit
(Vector) using 3,3′-diaminobenzidine-tetrahydrochloride-
dihydrate (DabSafe, Saveen Werner, Sweden), 8% NiCl, and
3% H2O2. Bright-field pictures were acquired using an
Olympus BX60 microscope (Sweden). Fluorescent labelling
was imaged using a confocal laser-scanning microscope
(Zeiss LSM 510, Germany).
Human Brain Tissue Five-micron-thick formalin-fixed par-
affin-embedded slices were evaluated by a pathologist before
serial sections were stained. The presence of infarct and infarct
age was confirmed by microscopy of the tissue in the imme-
diate proximity to the areas sampled and analyzed. Brain
slices were deparaffinized, immersed in lectin buffer (LB:
0.1 M Tris-buffer pH 7.6, 1.45 M NaCl, 0.01 M MgCl2,
0.01 M CaCl2) for 1 h and quenched in 1% H2O2 and 90%
methanol for 20 min. Following rinses in LB, antigen retrieval
was performed by microwave boiling in 0.01 M citrate buffer
pH 6.0 for 15min and slices were left in the solution until they
reached RT. After rinsing in LB, sections were blocked in 1%
bovine serum albumin (BSA, Sigma, USA) for 1 h and incu-
bated with biotinylatedWisteria floribunda agglutinin (WFA,
1:200, L1516, Sigma, USA) for 40 min at 37 °C in LB. After
rinsing in LB, ABC and DAB steps followed the same proto-
col used for rat sections. Bright-field pictures were acquired
using an Olympus BX60 microscope (Sweden).
Infarct Volume Measurements
For each animal in group I, ten coronal 30-μm-thick brain
sections with a distance of 1.0 mm were immunostained with
a monoclonal mouse anti-NeuN antibody (MAB377,
Millipore, USA) at a dilution of 1:1500. The sampling ranged
from 4.20 to −3.80 mm from bregma and covered the entire
rostro-caudal extension of the lesion. The non-lesioned area of
the infarcted hemisphere and the non-lesioned contralateral
hemisphere were outlined on each brain section using the
ImageJ software (National Institute of Health, USA). Infarct
volumes were determined by subtracting the area of the non-
lesioned ipsilateral hemisphere from that of the intact contra-
lateral hemisphere and calculated by volumetric integration
for each animal [38].
Cell Counting
Bright Field Microscopy In group I, three coronal sections
per brain (2.20, 0.48, and −3.30 mm relative to bregma) were
stained for Cat-315 as described above. Composite micro-
graphs of the whole ipsilateral and contralateral hemispheres
were acquired through a ×4 magnification objective using the
CellSens Dimension Software (Olympus BX60, Sweden). An
optical grid was used to define distances and draw the bound-
aries of the primary somatosensory cortex in both hemispheres
according to the Paxinos atlas [37]. The sizes of the areas of
interest were 6.55 mm2 at 2.20 mm from bregma, 10.90 mm2
at 0.48 mm from bregma, and 8.34 mm2 at −3.30 mm from
bregma.
Confocal Microscopy One coronal section per brain
(0.48 mm relative to bregma) was double-stained for Cat-
315 and parvalbumin as described above. Three areas of
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interest within the somatosensory cortex (layers II–III) were
acquired using a confocal laser-scanning microscope ×20 ob-
jective (Zeiss LSM 510, Germany). For analysis, the ImageJ
software was used to discriminate between the different
fluorophores. Cat-315+ cells, parvalbumin+ cells, and cells
positive for both antibodies were counted. Data are presented
as an average of the three regions of interest (ROIs).
Protein Extraction and Quantification
For group II and human tissue, regions of interest were disso-
ciated in TNT buffer, pH 7.4 (50 mM Trizma base, 150 mM
NaCl, 0.5% Triton X-100) and centrifuged at 12,000g for
15 min at 4 °C. Supernatants were collected and protein de-
termination performed with the Pierce BCA protein Assay Kit
according to the manufacturer (ThermoFisher Scientific,
USA). Twenty-microgram aliquots were prepared and stored
at −80 °C until further use.
Gel-Zymography Assays
MMP-2 and MMP-9 Zymography Equal amounts of pro-
teins (20 μg) were mixed with 5× sample buffer and separated
at 4 °C under non-reducing conditions on 8% SDS-PAGE gels
copolymerized with FITC-labeled gelatin (FITC 200 μg/ml,
Sigma, USA; gelatin 20 mg/ml, Sigma, USA) as in [39]. Gels
were washed in 2.5% Triton X-100 (2 × 30 min, RT) to re-
move SDS, and then incubated in activation buffer (50 mM
Tris-HCl pH 7.5, 10 mM CaCl2, 1 μM ZnCl2, 1% Triton
X-100, 0.02% NaN3) for 48 h at 37 °C to allow in-gel MMP
renaturation [40]. Zymograms were digitized with a
ChemiDoc XRS+ system (Bio-Rad, USA) under UV light
and proteinase activity quantified by densitometry (ImageJ,
USA).
tPA Zymography Equal amounts of proteins (20 μg) were
mixed with 5× sample buffer and separated at 4 °C under non-
reducing conditions on 12% SDS-PAGE gels copolymerized
with casein (10 mg/ml, Sigma, USA) and plasminogen
(2.5 μg/ml, Calbiochem, USA). Gels were washed at 4 °C
with cold 2.5% Triton X-100 (2 × 30 min) and cold distillated
water (3 × 10 min), and then incubated in activation buffer
(100 mM glycine pH 8.3, 10 mM EDTA) for 5.5 h at 37 °C to
allow caseinolysis. Gels were stained with Coomassie Blue
R-250 and destained with 40%methanol and 10% acetic acid.
Zymograms were digitized with a CanoScan 8800F (Canon,
USA) and proteinase activity quantified by densitometry
(ImageJ, USA).
Western Blot
β-Dystroglycan (β-DG) Equal amounts of proteins (20 μg)
were mixed with 5× sample buffer and separated at RT under
reducing conditions on 10% SDS-PAGE gels. Proteins were
transferred onto polyvinylidene difluoride (PVDF) mem-
branes (Millipore, USA) for 1 h at RT and blocked with a
solution containing 5% non-fat dry milk for 1 h at RT.
Membranes were incubated overnight at 4 °C with primary
antibody monoclonal mouse anti β-DG (1:500, ab49515,
Abcam, UK) in 5% BSA. On the next day, membranes were
incubated with a horseradish peroxidase (HRP)-conjugated
anti-mouse IgG (1:10,000, A3862, Sigma, USA) for 1 h at
RT. Protein bands were visualized by exposing the mem-
branes to a CCD camera (LAS1000, Fujifilm, USA) using a
chemiluminescent HRP substrate kit (Millipore, USA).
Membranes were stripped and re-probed with an anti-β-actin
HRP-conjugate (1:75,000, A3854, Sigma, USA). After densi-
tometric analysis using the ImageJ software (National Institute
of Health, USA), primary antibody levels were normalized to
β-actin expression.
Aggrecan Protein samples (20 μg) were treated with diges-
tion buffer containing 100 mM Tris-HCl pH 8.0, 30 mM
NaAc, 5 mM EDTA and protease inhibitors (Complete
EDTA-free, Roche, Germany) with (+) or without (−)
chondroitinase ABC (ChABC) (0.5 U/ml, Sigma, USA) at
37 °C for 3 h to remove chondroitin sulfate chains from the
aggrecan proteoglycan. ChABC treatment induces a gel shift
of the protein targets for the Cat-315 antibody, which we used
to detect aggrecan. The shift diminishes the smear of immu-
noreactive aggrecan peptides, leaving a marked protein band
at >250 kDa and weaker bands at lower molecular weights.
Proteins were then denatured and processed as above.
Western blots for the Cat-315 antibody (1:5000, MAB1581,
Millipore, USA) were ran on 4–15% gradient SDS-PAGE
gels.
RNA Extraction and Quantification
In group II, total RNAwas isolated from our regions of inter-
ests with TRI reagent (Sigma, USA) according to the manu-
facturer. Total RNA was treated with TURBO DNase
(Ambion, France) to avoid DNA contamination and was
quantified by spectrophotometry (NanoDrop Technologies,
USA). First-strand cDNA synthesis was performed from
1 μg of total RNA with the M-MLV Reverse Transcriptase
(Invitrogen, France) in a total volume of 20 μL with the fol-
lowing cycle conditions: 37 °C (50 min); 70 °C (15 min). RT-
qPCR was performed from 1 μL of 1:20 diluted cDNA in
15 μL total of a 1× solution of iQ SYBR Green Supermix
(Bio-Rad, France) containing 200 nM of each primer. Based
on mRNA coding sequences (www.ensembl.org), rat-specific
primers (see Table 1) were designed by using the Primer3Plus
software (http://www.bioinformatics.nl/cgi-bin/primer3plus/
primer3plus.cgi). Assays for the 40 samples were run in
triplicate on the CFX96 real-time system c1000 thermal cycler
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(Bio-Rad, France), with the following cycle conditions: 95 °C
(3 min); [95 °C (2 s), 60 °C (20 s)] × 39; 70 °C (30 s). To
investigate the best normalization process for reference genes,
we used the geNorm algorithm associated to qBase+™ soft-
ware and the Normfinder algorithm (Supplement Fig. 1) as
previously described [41].
A housekeeping gene study preceded the real gene expres-
sion analysis. By using the geNorm and the Normfinder
methods, we studied the stability of eight common reference
genes under our experimental conditions (β-actin BActb,^
glyceraldehyde-3-phosphate dehydrogenase BGapdh,^
hydroxymethylbilane synthase BHmbs,^ hypoxanthine-
guanine phosphoribosyltransferase BHprt,^ peptidylprolyl
isomerase A or cyclophilin A BPpia,^ peptidylprolyl isomer-
ase B or cyclophilin B BPpib,^ ribosomal protein L13a
BRpl13a,^ succinate dehydrogenase complex subunit A
BSdha^). Finally, two reference genes (BPpib^ and
BRpl13a^) were chosen for normalization in the study of our
genes of interest (a disintegrin and metalloproteinase with
thrombospondin motifs 4 BAdamts4,^ metalloproteinase 9
BMmp9,^ tissue plasminogen activator BPlat,^ neuroserpin
BSerpin1,^ tissue inhibitor of metalloproteinase 1 BTimp1,^
tissue inhibitor of metalloproteinase 3 BTimp3^).
Statistical Analysis
Statistical analysis was performed using the PRISM 7 soft-
ware (GraphPad, USA). In all experiments, P < 0.05 was
considered significant. Data are presented as means ± standard
error of the mean (SEM) unless otherwise stated. When com-
paring two groups, the two-tailed unpaired Student’s t test was
used in all cases except for behavioral analysis where the
Mann-Whitney U test was employed. Ordinary one-way
ANOVA was used when comparing more than two groups
and in significant cases followed by the Bonferroni’s multiple
comparisons test.
Results
EE Promotes Behavioral Recovery of Limb Placement
Ability After PT Without Affecting Infarct Size
Consistent with previous work [12], the PT procedure resulted
in local thrombosis of cortical microvessels and subsequent
ischemic focal infarction in the left primary motor cortex. No
signs of lesion could be detected in sham-operated animals
(data not shown). Figure 2a shows a comparable localization
of the lesion for the stroke STD and stroke EE groups. The
lesion extended from the cortical surface down to the corpus
callosum, without transecting the white matter. Importantly,
the infarct volume at 7 days after PT and 5 days after differ-
ential housing conditions was 33.64 ± 4.28 mm3 for the stroke
STD animals and 34.28 ± 6.38 mm3 for the stroke EE animals
(Fig. 2b). Therefore, no significant difference between the two
Table 1 Reference genes and primer sequences




Actb agccatgtacgtagccatcc accctcatagatgggcacag NM_031144.3 115 100.8
Gapdh gtgatgctggtgctgagta gcggaaggggcggagatg NM_017008.4 115 77.2
Hmbs aggatgggcaactgtacctg aactgtgggtcatcctctgg NM_013168.2 130 85.1
Hprt1 gcagactttgctttccttgg agaggtccttttcaccagca NM_012583.2 79 86.3
Ppia catcctgaagcatacaggtc catccagccactcagtctt NM_017101.1 107 98.7
Ppib caagacctcctggctagacg ttctccaccttccgtaccac NM_022536.2 81 87.6
Rpl13a gatgaacaccaacccgtctc atcccatccaacaccttgag NM_173340.2 141 90.5
Sdha cgagatccgtgaaggaagag ctctgagatcccaggcagac NM_130428.1 109 90.0
Gene expression study
Ppiba caagacctcctggctagacg ttctccaccttccgtaccac NM_022536.2 81 98.9
Rpl13aa gatgaacaccaacccgtctc atcccatccaacaccttgag NM_173340.2 141 98.9
Adamts4 aactccctgttccccagact tagcttcagggccaggtaga NM_023959.1 271 91.4
Mmp9 cactgtaactgggggcaact cacttcttgtcagcgtcgaa NM_031055.1 150 103.8
Plat tctgccgcccactgctttg cgaatgtctgctcctcctctcc NM_013151.2 103 106.7
Serpin1 atgaggctggtggcatctac gatcagctgtggtttgagca NM_053779.1 131 99.8
Timp1 ggttccctggcataatctga atggctgaacagggaaacac NM_053819.1 99 101.2
Timp3 gctgtgcaactttgtggaga aattgcaacccaggtggtag NM_012886.2 86 93.6
a Used as housekeeping genes
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groups was present, consistent with other work in which EE
was initiated at 2 days after PT [12, 13].
On day 2, after stroke and prior to differential housing
conditions, all animals subjected to sham operation showed
no deficit in the paw placement test (score = 1 for both paws;
data not shown). On the contrary, all animals subjected to PT
exhibited a clear deficit in both forepaw and hindpaw function
(score = 0 in the paws contralateral to the side of the lesion;
data not shown). On day 7 of recovery, despite equivalent
infarct volumes, we observed a significant improvement in
limb placement ability (contralateral to the side of the lesion)
in the stroke EE group compared with the stroke STD group
(Fig. 2c–e). Sham animals did not show any deficit, and their
scores are not included in the graphs. Animals housed for
5 days in EE conditions after PT exhibited a significant recov-
ery of forepaw function (P < 0.01, Fig. 2c), with 66% of the
animals showing complete recovery (score = 1, four rats out of
six) and 33% showing improved function (score = 0.5, two
rats out of six). Also, 50% of the stroke EE animals exhibit an
improved hindpaw sensorimotor function (score = 0.5 in three
rats out of six, Fig. 2d). Figure 2e shows the sum of scores for
both paws, with a score = 2 indicating full recovery of the
paws contralateral to the lesion (forepaw = 1 + hindpaw = 1).
The entire stroke EE group developed some improved
function 7 days after stroke, with one third of the rats scoring
1.5 points, half of them scoring 1 point and one quarter show-
ing 0.5 point (P < 0.01). On the contrary, all animals housed in
STD conditions showed complete deficit in both forepaw and
hindpaw limb placement ability, described by the lowest score
in the test (score = 0, six rats out of six, Fig. 2c–e).
Taken together, these data show that 5 days of EE condi-
tions initiated 2 days after PT induce a robust recovery of
forepaw function and improved recovery of hindpaw
function.
PTand EE Diminish the Number of PNNs and Increase
the Level of Cat-315+ Peptides
To determine whether EE modulates the presence of aggrecan
in the somatosensory cortex, cell counting was performed to
study changes in its immunoreactivity at 7 days of recovery
(Fig. 3).
Cell counting results are summarized in Fig. 3a (2.20 mm
from bregma, level 1), Fig. 3b (0.48 mm, level 2), and Fig. 3c
(−3.30 mm, level 3). These specific bregma distances always
presented an infarct and were selected in order to cover the
vast majority of the somatosensory cortex. Results among
groups were analyzed independently for the ipsilateral and
Fig. 2 Infarct measurements and paw placement test. a Serial coronal
slides of a representative brain infarct from the stroke standard (STD) and
stroke enriched (EE) groups. b Infarct volume measurements 7 days after
photothrombosis. Two-tailed unpaired Student’s t test, n = 5 for each
group. c–e Limb placement ability of rats subjected to photothrombotic
stroke (PT, left hemisphere). Scores are shown as individual data points
with group median and interquartile range. During the pretest (before
surgeries), all rats exhibited a score = 1 in all four paws, indicating no
deficits. At day 2 of recovery, all rats subjected to PT (stroke STD; stroke
EE) exhibited a score = 0 on the right forepaw and hindpaws, indicating
full deficits in the placement of both limbs contralateral to the lesion. c
Scores for forepaw placement (**P < 0.01), d hindpaw placement, and e




contralateral hemispheres. In both shams and stroke animals,
PNNs were localized mainly between layers II and VI of the
cortex and the immunoreactivity revealed a lattice-like struc-
ture surrounding the cell body and proximal dendrites. In
sham animals, the distribution of PNNs varied substantially
across cortical areas where the primary somatosensory cortex,
auditory cortex, and retrosplenial cortex resulted richest in
PNNs (data not shown). Statistical analysis showed significant
differences among the four experimental groups in the ipsilat-
eral hemisphere of all three levels (P < 0.001, Fig. 3a–c). A
general decrease in the number of PNNs was seen after stroke
and a further decrease in the number of nets was seen in the
stroke EE group. In the contralateral hemisphere, these differ-
ences were not present among the groups and the number of
PNNs was not affected by stroke. Importantly, differential
housing conditions did not alter the number of PNNs in sham
animals.
In the ipsilateral hemisphere of level 1 (Fig. 3a), post
hoc comparisons showed significant difference between
the sham STD and stroke STD groups (P < 0.001). Cell
counting from level 1 show a reduction of 51 and 72% in
the number of PNNs after stroke or stroke and EE condi-
tions, respectively, compared to shams. In level 2 (Fig. 3b),
the analysis showed differences similar to level 1, and here,
the comparison between the stroke STD and the stroke EE
groups reached statistical significance (sham STD vs
stroke STD P < 0.05; stroke STD vs stroke EE P < 0.01).
Cell counting from level 2 indicates a reduction in the
number of PNNs of 28 and 67% in the stroke STD group
and stroke EE group, respectively, compared to shams.
Comparable results were seen in level 3 (Fig. 3c) (sham
STD vs stroke STD P < 0.05; stroke STD vs stroke EE
P < 0.01). In this level, the reduction seen in the number
of PNNs was 27 and 62% when comparing shams with
stroke STD and stroke EE, respectively.
Figure 3d–i′ shows representative micrographs of PNNs
in the rat cortex. Figures 3d–e and d′–e′ (in higher magnifi-
cation) illustrates the robust presence of nets in sham ani-
mals, thick and dispersed between layers II and IV.
Figures 3f–g displays the nets of a stroke STD animal. In
this case, the nets are quite reduced in number in the ipsilat-
eral hemisphere compared to shams or the contralateral side.
Also, the thickness of the nets seems altered by the stroke
since they appear thinner (Fig. 3f′ and g′) compared to the
shams animals. PNNs of a stroke EE rat are shown in
Fig. 3h–i, where they appear barely visible in the ipsilateral
hemisphere. Figure 3h′ displays the morphological appear-
ance of some very thin and interrupted nets in the ipsilateral
hemisphere of a stroke EE rat, which appear almost degrad-
ed compared to the contralateral side (Fig. 3i′).
To determine whether the EE-induced reduction of PNNs
in the cortex after PT is accompanied by a change in the
cortical levels of the aggrecan protein, western blot studies
were performed on cortical homogenates 7 days after PT and
5 days after EE. Figure 3j shows representative western blots
of protein samples from the somatosensory cortex of the ipsi-
lateral hemisphere. Samples were treated with (+) or without
(−) ChABC. The Cat-315 antibody detected a smear of immu-
noreactivity and multiple bands between ∼200 and 330 kDa
on the western blots, which were quantified. Densitometric
analyses of the sham groups did not show significant differ-
ences between the STD and EE groups (Fig. 3k). Likewise,
among the stroke groups, protein levels were not altered in the
absence of ChABC. Treatment with ChABC sharpened the
protein bands and removed much of the smear above the main
protein band at 250 kDa (Fig. 3j). In ChABC-treated samples,
the integrated level of Cat-315+ peptides increased by 35%
(P < 0.05) in the stroke EE group compared to the stroke
STD group (Fig. 3k).
In summary, these data show that PT induces a reduction in
the number of PNNs in the ipsilateral hemisphere of the so-
matosensory cortex visible 7 days after surgery. Interestingly,
PT and 5 days of EE conditions further reduce the number of
PNNs, which is visible in two of the three levels analyzed. The
enhanced decrease of PNNs under EE conditions is accompa-
nied by an increase in the levels of Cat-315+ aggrecan and
what appears to be aggrecan fragments.
EE Promotes a Decrease of Cat-315+ PNNs
Around PV/GABA Neurons
To reveal the identity of neurons that were enwrapped with
PNNs in the somatosensory cortex, we performed a double
immunofluorescent staining of PNNswith Cat-315 (aggrecan)
and PV (marker for a subset of GABAergic neurons). In
Fig. 4, we show the results from the counting of nets stained
with Cat-315, PV, and the nets that express both markers.
Fig. 3 Bright-field cell counting, microscopy, and western blot of
aggrecan in the rat somatosensory cortex. Cell counting of Cat-315+
PNNs at 7 days of recovery at different distances from bregma (a
2.20 mm, b 0.48 mm,c −3.30 mm). Results among groups were
analyzed independently for the (IPSI) ipsilateral and (CONTRA)
contralateral hemispheres. IPSI: a sham STD vs stroke STD
(***P < 0.001); b sham STD vs stroke STD (*P < 0.05), stroke STD
vs stroke EE (**P < 0.01); c sham STD vs stroke STD (*P < 0.05), stroke
STD vs stroke EE (**P < 0.01). One-way ANOVA and Bonferroni’s
multiple comparisons test, n = 5 for each group. d-i' Representative
bright-field micrographs of Cat-315+ PNNs immunoreactivity in the
somatosensory cortex. d'-i' Higher magnification. Black arrows are
pointing at Cat-315+ PNNs degraded by stroke. j Representative Cat-
315 western blots of protein homogenates from the somatosensory
cortex of the IPSI hemisphere. Homogenates were digested with (+) or
without (−) ChABC. k Densitometric analyses of Cat-315 western blots
where data were normalized toβ-actin expression. Significant differences
were found in the comparison stroke STD (+) vs stroke EE (+), *P < 0.05.
Two-tailed unpaired Student’s t test, n = 3 per group. AU arbitrary units,
STD standard, EE enriched
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Figure 4a displays the results for the ipsilateral and contra-
lateral hemispheres. In the ipsilateral hemisphere, the Cat-
315+ PNN counting showed statistical significance when
comparing our four experimental groups (P < 0.001) and
mainly between stroke STD vs stroke EE (P < 0.001). The
number of PNNs was reduced in the stroke EE group; how-
ever, shams did not present this reduction, suggesting that
differential housing conditions Bper se^ are not responsible
for the decrement seen in the stroke EE group. Cell counting
revealed a 61% reduction of PNNs in the stroke EE compared
to shams. When analyzing for differences in PV+ cells, we did
not observe any statistical significance. When looking at the
numbers of nets positive for both markers, we found statistical
significance (P < 0.01) and especially when comparing stroke
STD vs stroke EE groups (P < 0.01). The stroke EE group had
50% fewer PNNs compared to shams and stroke STD groups.
In the contralateral hemisphere, no significant difference was
observed between the experimental groups and relative to the
different marker expressions.
A representative double immunohistochemical staining in
Fig. 4b reveals that most of the PV+ cells (described in green)
are surrounded by Cat-315+ PNNs (depicted in red) in a rep-
resentative rat from the sham STD group. Figure 4c–c″
displays these details in higher magnification, and this
coexpression is also seen in the rest of the experimental groups
(data not shown).
Overall, these results reveal that the number of PV+ cells in
the somatosensory regions is neither altered by stroke nor by
our EE conditions. Therefore, the reduction in the number of
PNNs enwrapping PV+ cells that we observe after stroke and
EE conditions cannot be attributed to a relative reduction in
the number of PV+ cells.
MMP-9 and tPA Proteolytic Activities Are Increased After
PT and EE Conditions
To examine the influence of EE on the proteolytic activity of
ECM proteases such as endogenous gelatinases (MMP-2 and
MMP-9) and tPA, gel-zymography was performed in samples
from the somatosensory cortex of both ipsilateral and contra-
lateral hemispheres (Fig. 5).
MMPs gelatinolytic activity produced two bands at
∼72 and ∼92 kDa, respectively (Fig. 5a). Since the
proforms and active forms of MMP-2 and MMP-9 were
not distinguishable on the zymogram, the two bands were
quantified as total MMP-2 and MMP-9 activity,
Fig. 4 Confocal cell-counting andmicroscopy of parvalbumin (PV)+ and
PV-aggrecan+ PNNs in the rat somatosensory cortex. a Results from the
counting of nets stained with PV, Cat-315, and the nets that expressed
both markers at 7 days of recovery (0.48 mm from bregma). Means are
intended as mean average number of cells for three regions of interest
(ROIs). Results among groups were analyzed independently for the Cat-
315, PV, and merged stainings and for the ipsilateral hemisphere (IPSI)
and contralateral hemisphere (CONTRA). IPSI: Cat-315 staining, stroke
STD vs stroke EE (***P < 0.001); merged staining, stroke STD vs stroke
EE (**P < 0.01). bRepresentative double immunostaining for PV (green)
and Cat-315 (red) from the somatosensory cortex of a sham STD rat, c-c''
higher magnification. One-way ANOVA and Bonferroni’s multiple
comparisons test, n = 5 for each group. STD standard, EE enriched
(color figure online)
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respectively. As shown in Fig. 5b, EE led to an increase in
MMP-9 activity in stroke EE animals compared to stroke
STD animals in the ipsilateral hemisphere (P < 0.01, 40%
increase).
tPA casein-plasminogen zymography produced one clear
band on a dark background at ∼70 kDa whichwe quantified as
total tPA activity (Fig. 5c). As seen in Fig. 5d, tPA proteolytic
activity was increased in the ipsilateral hemisphere of stroke
EE animals, when compared to stroke STD animals (P < 0.05,
12% increase).
These results demonstrate that exposure to an EE for 5 days
after PT elevates the activity of the ECM proteases MMP-9
and tPA in the ipsilateral somatosensory cortex but has no
effect on MMP-2 activity.
Since the activity of MMP-9 was increased by EE, we next
studied the protein levels of β-dystroglycan, a candidate
Fig. 5 MMP-2, MMP-9, and tPA proteolytic activities in the rat
somatosensory cortex. a Representative FITC-gel zymography of
MMP-2 and MMP-9 appear as two clear bands on a dark background
at 72 and 92 kDa (MMP-2 and MMP-9, respectively). b Densitometric
analyses of MMP-2 and MMP-9 activities in the ipsilateral (IPSI) and
contralateral (CONTRA) hemispheres. Significant differences were
found in MMP-9 activity in the IPSI hemisphere of stroke injured rats:
stroke STD vs stroke EE (MMP-9, **P < 0.01). c Representative casein-
plasminogen zymography of tPA appear as one clear band on a dark
background at 70 kDa. d Densitometric analyses of tPA activity in the
IPSI and CONTRA hemispheres. Significant differences were found in
tPA activity in the IPSI hemisphere of stroke injured rats: stroke STD vs
stroke EE (tPA, *P < 0.05). e Representative western blot of β-
dystroglycan, a substrate of MMP-9, appear as two dark bands on a
clear background at 43 and 30 kDa. The 43-kDa band represent the
full-length form of the protein and the 30-kDa band represent a
proteolytic fragment. f Densitometric analyses of β-dystroglycan protein
expression in the ipsilateral (IPSI) and contralateral (CONTRA)
hemispheres where data were normalized to β-actin expression. IPSI:
stroke STD vs stroke EE (30-kDa form, *P < 0.05). Two-tailed
unpaired Student’s t test, n = 4 for sham STD and sham EE, n = 5 for
stroke STD and stroke EE. AU arbitrary units, STD standard, EE enriched
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physiological brain target molecule of MMP-9. Figure 5e
shows representative western blots of β-dystroglycan in the
somatosensory cortex of both ipsilateral and contralateral
hemispheres. The β-dystroglycan antibody detected two
bands at ∼43 and ∼30 kDa, respectively. Statistical analyses
(Fig. 5f) showed no differences in the levels of the 43-kDa
form between both shams and stroke groups, in the ipsilateral
and contralateral hemispheres, respectively. The 30-kDa form
of β-dystroglycan was increased in the stroke EE group com-
pared to the stroke STD group in the ipsilateral hemisphere
(P < 0.05, 40% increase). These data indicate that PT + EE
conditions induce an increased cleavage of β-dystroglycan, a
target of MMP-9 activity.
RT-qPCR Shows Modulation of ECM Protease
and Protease Inhibitor mRNA Expressions
in the Somatosensory Cortex After PT
In order to discern if the increased activity of MMP-9 and tPA
that we see in the stroke EE group was due to changes in
expression of respective ECM proteases, mRNA levels of
Mmp9, as well as Adamts4, Tpa, and their inhibitors (respec-
tively, Timp1, Timp3, and Neuroserpin) were studied by RT-
qPCR (Fig. 6). Data from the four experimental groups were
analyzed relative to each protease or inhibitor of interest. In
both hemispheres, mRNA for all our ECM proteases and in-
hibitors of interest were constitutively expressed in sham and
stroke tissue. Figure 6a shows mRNA levels in the ipsilateral
hemisphere, where Timp1 mRNA expression after PT in-
creased significantly by 70% (P < 0.05 among our four exper-
imental groups; sham STD vs stroke STD, P < 0.05).
Figure 6b shows mRNA expression in the contralateral hemi-
sphere. Here, Adamts4 mRNA expression was statistically
45% higher in the stroke STD group compared to the sham
STD group (P < 0.05 among our four experimental groups;
sham STD vs stroke STD, P < 0.05).
In summary, PT induces an increase in the mRNA expres-
sion of the ECM protease inhibitor Timp1 in the ipsilateral
hemisphere. In the contralateral hemisphere, PT induces an
increase in Adamts4 mRNA expression which is then down-
regulated by PT + EE conditions. These data suggest a mod-
ulation of the expression levels of ECM proteases and prote-
ase inhibitors after PT that could potentially influence the
ECM proteases activity and the degradation/reduction of
PNNs seen after stroke.
Stroke Affects the Structure of PNNs and the Activity
of MMP-2, MMP-9, and tPA in the Human Brain
To translate and assess the relevance of our experimental
studies to stroke patients (Fig. 7), human cortical brain
tissue of stroke and non-stroke patients was analyzed for
the presence of WFA, a marker for PNNs in the brain
cortex and analyzed with respect to MMP-2, MMP-9,
and tPA activities by gel zymography. Figure 7a shows a
representative low-magnification micrograph cortical
brain section of a control case. In this picture, some
WFA+ PNNs are visible and dispersed in the cortical tis-
sue of the patient. At higher magnification (Fig. 7a′),
the detailed structure of the PNN appears thick, covering
the cell-soma and a long dendrite. Figure 7b shows a
representative peri-infarct cortical brain section of a pa-
tient who suffered from an acute stroke (a few days before
death). Here, the PNNs appear thin and interrupted, barely
visible, and a similar structure is visible in Fig. 7c
which shows a representative peri-infarct cortical brain
section of a patient after a chronic stroke (months before
Fig. 6 mRNA expression of ECM proteases and protease inhibitors in
the rat somatosensory cortex. RT-qPCR of Adamts4, Mmp9, Tpa, and
their respective inhibitors Timp3, Timp1, Neuroserpin in the ipsilateral
(IPSI) and contralateral (CONTRA) hemispheres. Data from the four
experimental groups were analyzed relative to each protease or inhibitor
and normalized to the housekeeping genes Ppib and Rpl13a. a IPSI:
Timp1, sham STD vs stroke STD *P < 0.05. b CONTRA: Adamts4,
sham STD vs stroke STD *P < 0.05, stroke STD vs stroke EE
*P < 0.05. One-way ANOVA and Bonferroni’s multiple comparisons
test, n = 4 for sham STD and sham EE, n = 6 for stroke STD and
stroke EE. STD standard, EE enriched
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death). Figure 7d shows the activity of MMP-2 and
MMP-9 in a control case and after stroke of the human
cortex. In the control case, two bands are visible around
100 and 70 kDa, in similar positions to our rat study.
After stroke, the activity of the two MMPs appears upreg-
ulated in the human cortex. Two more bands are visible in
the gel (at >170 and at 130 kDa) showing the activity of
the proteases in the peri-infarct (PI) and a cortical region
remote from the infarct (R). Quantification of the MMP-2
and MMP-9 bands shows increased activity of MMP-9 in
stroke patients compared to non-stroke (Fig. 7e;
P < 0.05 in non-stroke vs PI and non-stroke vs R). tPA
activity also appear increased after stroke, in both PI and
R regions of the cortex (Fig. 7f). In this case, two bands
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are visible between 70 and 55 kDa, at the same molecular
weight of a tPA control produced by recombinant DNA
technology (Actilyse, Boehringer Ingelheim, Germany;
data not shown). Quantification of the tPA bands shows
increased activity of the protease in stroke patients com-
pared to non-stroke (Fig. 7g; P < 0.05 in non-stroke vs PI
and non-stroke vs R).
Discussion
In the present study, we demonstrate that multisensory stimu-
lation, provided by housing rats in an EE for 5 days after
experimental stroke enhances recovery of paw placement abil-
ity, without affecting infarct size. This is accompanied by in-
creased activity of the ECM proteases MMP-9 and tPA.
Concomitantly, protein substrates of these enzymes are mod-
ified as evidenced by a decreased number of PNNs
enwrapping PV/GABA-containing neurons in the somatosen-
sory cortex, by an increased degradation of aggrecan, the main
constituent of PNN, and an increased cleavage of β-dystro-
glycan. In the following, we will discuss the implication of our
results for stroke recovery and rehabilitation of stroke patients.
Multisensory Stimulation of the Brain After Stroke
Enhances Recovery of Neurological Functions
Studies in stroke patients and in animal stroke models show
that most recovery from impairment occurs in the first weeks
after stroke and that multiple mechanisms are involved in the
recovery process [6]. Among others, a sensitive period of
postischemic plasticity defined by unique genetic, molecular,
physiological, and structural events results in both spontane-
ous tissue reorganization and increased responsiveness to
sensori stimulation and training [46]. In this study, experimen-
tal stroke was induced in the forepaw and hindpaw primary
motor areas and this lesion caused a complete deficit in the
tactile/proprioceptive response to sensory stimuli in rats [12,
36]. EE initiated 2 days after stroke and continued for 5 days,
reversed this deficit in the forepaw and augmented the recov-
ery of hindpaw function. Importantly, analysis of the infarct
volume among the stroke groups did not show disparities,
suggesting that the recovery-promoting effect of EE cannot
be attributed to a smaller infarct volume but mainly to mech-
anisms of brain plasticity, such as experience-driven re-learn-
ing [6, 47]. This is in agreement with previous studies refer-
ring to environmental enrichment as a stimulating environ-
ment with respect to novelty, variety, social interactions, and
reward which enhance spontaneous biological recovery in ro-
dents even in the absence of specific training [46, 48–52].
Multisensory Stimulation of the Brain After Stroke
Reduces the Number of Aggrecan+ PNNs and Increases
Aggrecan Proteolysis
One current hypothesis on impairment of recovery after stroke
proposes that an imbalance between excitation and inhibition
develops during stroke recovery and leads to a net increase in
inhibition of cortical microcircuits of the injured hemisphere
[53]. This inhibition is gated by PV/GABA interneurons, fre-
quently enwrapped by PNNs. PNNs carry strong cation-
binding properties of the CSPG chains which modulate the
activity of PV/GABA cells, and therefore the excitability of
cortical microcircuits. PV/GABA cells are also implicated in
our study.
CSPGs and aggrecan, in particular, are the main compo-
nents of PNNs. The structure and number of PNNs are mod-
ulated in areas distant from the infarct [12, 54]. CSPGs are
also released during reactive astrocytosis after stroke leading
to a substantial increase of their expression in the scar tissue
which is encapsulating the infarct [15]. The number of PNNs
and aggrecan expression increases during synaptogenesis
which coincides with the closing of the developmental critical
period, a time of enhanced structural and functional synaptic
plasticity [55, 56]. Evidences suggest that the poststroke brain
is in a state of heightened sensitivity to behavioral experience
reminiscent of the critical period [48, 57]. This is strongly
supported by our study, where a robust sensori-motor stimu-
lation provided by EE after stroke induced a reduction in the
number of Cat-315+ PNNs in the somatosensory cortex ipsi-
lateral to the lesion, where the Cat-315 antibody recognizes a
carbohydrate epitope carried on the aggrecan core protein [12,
42–45].
Generally, aggrecan that has undergone enzymatic diges-
tion of chondroitin sulfate chains with ChABC is detected
Fig. 7 PNN expression and ECM protease activities in the human brain
after stroke. Human brains of stroke and non-stroke cases have been
analyzed for the expression of WFA, a traditional marker for PNNs and
subjected toMMP-2,MMP-9, and tPA gel zymography. aRepresentative
picture of a cortical brain section from a control case. WFA+ PNNs are
visible and dispersed in the cortex of the patient. a'Higher magnification.
PNNs appear thick, enwrapping the cell-soma and a long dendrite. b
Representative peri-infarct cortical brain section of a patient who
suffered from an acute stroke. PNNs appear thin and disrupted. c
Representative peri-infarct cortical brain section of a patient after a
chronic stroke, where PNNs are barely visible. d FITC-gel zymography
showing MMP-2 and MMP-9 activity in the human cortex in a control
case and in a stroke patient. In the control case, two bands are visible
around 100 and 70 kDa. After stroke, two additional bands are visible in
the gel (at >170 kDa and at 130 kDa) in the peri-infarct (PI) and in a
cortical region remote from the infarct (R). e Quantification of MMP
zymography (*P < 0.05 non-stroke vs PI or R). f Casein-plasminogen
zymography showing tPA activity in the human cortex in a control case
and in a stroke patient. tPA activity in the control case appears as a faint
two-band zymogram between 70 and 55 kDa. After stroke, these bands
appear more prominent as seen in both the PI and R regions. g
Quantification of tPA zymography (*P < 0.05 non-stroke vs PI or R).
One-way ANOVA and Bonferroni’s multiple comparisons test, n = 3 for
non-stroke patients and n = 3 for stroke patients
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with a marked band at >250 kDa, but often multiple weaker
bands at lower molecular weights can also be identified on
western blots [58]. Here, we demonstrate that aggrecan, a
key component of PNNs, undergoes increased digestion fol-
lowing stroke and EE conditions even in cortical regions re-
mote from the lesion. Because aggrecan can be cleaved at
multiple sites, several fragments were identified on the west-
ern blots from shams and stroke animals. The increased diges-
tion suggests aggrecan proteolysis as an early step in PNNs
loss (visible here 7 days after stroke and after 5 days of EE),
similarly to what has been described after status epilepticus
[45].
Recently, the effects of manipulating CSPGs using ChABC
have been investigated after stroke in vivo [59]. It was dem-
onstrated that ChABC treatment was able to promote forepaw
sensorimotor recovery and degrade PNNs which may reacti-
vate plasticity. These findings are in line with our results,
where environmental stimulation drives functional recovery
and plasticity through the degradation of PNNs, which are
mainly enwrapping PV/GABA-containing neurons. PV/
GABA cells are key regulators of synchronization of neuronal
activity in cerebral microcircuits. These microcircuits, gated
by PV/GABA interneurons, play an important role in process-
ing information for many tasks such as motor control, cogni-
tion, and sensory perception [60], of importance in functional
recovery after stroke [61, 62]. Here, we show that under EE
conditions, PV-containing neurons were enwrapped by fewer
PNNs. The remaining PNNs had poor structural integrity,
suggesting that a digestion process may be responsible for
the loss of PNNs. Finally, we demonstrated the presence of
PNNs in the human brain, which appear similar to the ones
seen in our experimental model. In control patients, these nets
were thick and enwrapping the entire cell soma and proximal
dendrites, as reported earlier [63]. After stroke, the nets ap-
peared thin and disrupted, as seen in the rat brains after exper-
imental stroke. The degradation of PNNs could change the
kinetics and fast-spiking characteristics of the PV/GABA cells
[60]. Together, these data strongly suggest that multisensory
stimulation provided by EE induces a degradation of
aggrecan-containing PNNs, opening-up a critical period for
plasticity after stroke in the adult brain.
Multisensory Stimulation of the Brain After Stroke
Activates ECM Proteases
ECM proteases and their inhibitors are involved in PNNmod-
ulation after stroke. PNNs can be envisaged as targets for
pharmacological interventions as observed in seizure genesis
[64]. Different proteases have been proposed to contribute to
ECM modulation and degradation after brain injury, among
others tPA, ADAMTS-4, MMP-2, and MMP-9 [25, 28–31].
In our study, the activity of tPA andMMP-9 is increased in the
ipsilateral somatosensory cortex of the stroke EE group
compared to the stroke STD group. These proteases might
then be involved in the remodelling of ECM structures and
changes in the integrity of PNNs that we observe after stroke
and EE conditions in regions remote from the infarct. We also
showed an increased activity of tPA and MMPs after stroke in
human samples, suggesting similar processes in the human
brain following stroke. tPA expression and activity in the
healthy human cortex have been reported earlier [65] and
MMP-2 and MMP-9 activities have been studied in the ische-
mic core of stroke patients [66]. Our results in stroke patients
highlight a remarkable presence of tPA, MMP-2, and MMP-9
activities in peri-infarct zones and most importantly in regions
remote from the infarct. This suggests a predominant remod-
elling of the abovementioned areas after stroke in patients
which persists for months after the event.
Despite data implicatingMMP-9 in neuronal/synaptic plas-
ticity, not many synaptic targets for its enzymatic activity have
yet been identified. However, recent studies have suggested
that this enzyme may digest the full-lenght β-dystroglycan to
release a 30-kDa product, mainly expressed in the postsynap-
tic membrane and in close proximity to MMP-9 [32]. β-
Dystroglycan is a cell surface protein protruding from post-
synaptic membrane and bound (probably throughout the syn-
aptic cleft) to presynaptic neurexins, implicated in neurotrans-
mitter release and long-term potentiation (LTP) [67]. In this
study, we observed increased levels of the 30-kDa form of β-
dystroglycan, which may have been generated by MMP-9,
similar to previous reports where enhanced neuronal activity
was challenged [32, 68]. One explanation of this result could
be that the multisensory stimulation provided by EE induced a
MMP-9 activation-dependent cleavage of the full-length form
of β-dystroglycan in the ipsilateral hemisphere. A fine struc-
tural immuno-colocalization of β-dystroglycan and MMP-9
has been previously shown by electron microscopy in the rat
brain [32]. In addition, β-dystroglycan cleavage is abolished
after a MMP-9 inhibitor treatment [32] and in MMP-2 and
MMP-9 knockout mice [69], further suggesting a role of
MMP-9 in β-dystroglycan cleavage.
MMP activity is tightly controlled by endogenous tissue
inhibitors of MMPs (TIMPs), a family of proteins comprised
of four members (TIMP-1 to TIMP-4), which inhibit multiple
MMPs and display different interactions and substrate speci-
ficity with MMP proenzymes [70]. tPA activity in the CNS is
regulated by neuroserpin, a member of the serine protease
inhibitor (serpin) family that is secreted from the growth cones
of neurons [71]. It is important to note that protease expression
is not always indicative of net proteolytic activity, since the
latter is an outcome of expression levels, posttranslational ac-
tivation, and protease inhibition [34]. Interestingly, mRNA
expression analysis showed an upregulation of Timp1 in the
ipsilateral hemisphere after stroke. Timp1 has been shown to
be upregulated following focal ischemia, a process that could
be part of a general neuronal response that mediates tissue
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reorganization [72]. In our study, the upregulation of Timp1
supports this hypothesis and suggests that the observed chang-
es in MMP-9 and tPA activities are regulated by the expres-
sion of the corresponding inhibitors rather than by translation
of ECM protease genes. In the contralateral hemisphere,
Adamts4 mRNA expression was upregulated after stroke,
but not after stroke and EE conditions, a tendency also seen
in Timp3 and Neuroserpin. This suggests a transcallosal influ-
ence of the injured hemisphere on the contralateral hemi-
sphere protease mRNA expressions, which is prevented by
multisensory stimulation exerted through an EE. Adamts4
mRNA expression is upregulated in astrocytes following tran-
sient middle cerebral artery occlusion in the rat [73], but this is
the first study reporting their modulation in regions remote
from the lesion after permanent stroke. Similarly, Timp3 and
Neuroserpin are upregulated in penumbral cortical neurons
following stroke in the ipsilateral hemisphere [74, 75].
Conclusions
In conclusion, this study reports that experience-dependent
plasticity induced by housing rats in an EE after stroke reduces
the number and structure of aggrecan-containing PNNs sur-
rounding PV/GABA neurons in areas remote from the ische-
mic lesion. This reduction is accompanied by an upregulation
in the activity of ECM proteases such as tPA and MMP-9 and
a modulation in the expression of ECM proteases and inhibi-
tors such as Adamts4 and Timp1. Similar results were seen in
brain tissue from stroke patients. We conclude that multisen-
sory stimulation of the brain after stroke, which provides en-
hanced recovery of lost function, involves the modulation of
ECM proteases and protease inhibitors. Elucidating the mech-
anisms of ECM remodelling after stroke may contribute to the
development of new therapies supporting rehabilitation of
stroke patients.
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